IFI44L and pancreatic ductal adenocarcinoma: Although some study identified that IFI44L overexpressed in pancreatic ductal adenocarcinoma and correlated with worse clinical prognosis, this conclusion is only made from statistics of databases collecting from gene expression profiling and TCGA database but lacks in vitro and in vivo experimental confirmation [44].